The FDA will consider a second vaccine candidate, from Moderna Inc., at an advisory committee meeting on Dec. 17, and approval could come soon after. More vaccines are expected to be brought to market next year, expanding the arsenal doctors will have to rein in a virus that has killed almost 300,000 Americans.



Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *